Dhaka, Oct. 11 -- A gene therapy based on Nobel prize-winning science has partially restored sight in some blind patients, with a clinical trial reporting improved light sensitivity and no lasting serious treatment-related complications, The Guardian reports.

The treatment, known as optogenetic therapy, was tested on 10 people with advanced retinitis pigmentosa, a group of genetic disorders that gradually destroy light-sensitive cells in the retina.

According to The Guardian, the therapy uses a single injection to make surviving retinal nerve cells sensitive to light. Patients then wear specialised goggles that convert images into light pulses, enabling them to perceive monochrome images.

Six participants experienced clinically meaning...